NCT00678054View on ClinicalTrials.gov

Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

August 11, 2000

Study Completion Date

October 23, 2015

Conditions
Prostate Cancer
Interventions
DRUG

GM-CSF

Each cycle will consist of 28 days. Patients will receive 250 ug/m2/day of GM-CSF administered subcutaneously on days 1-14.

Trial Locations (1)

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER